Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Okayama prospective oBservational study of the Effect by Sitagliptin on obesE type2 diabetes

Trial Profile

Okayama prospective oBservational study of the Effect by Sitagliptin on obesE type2 diabetes

Status: Completed
Phase of Trial: Phase IV

Latest Information Update: 06 Aug 2015

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Sitagliptin (Primary)
  • Indications Type 2 diabetes mellitus
  • Focus Biomarker; Therapeutic Use
  • Acronyms OBESE

Most Recent Events

  • 04 Aug 2015 Status changed from active, no longer recruiting to completed as reported by University Hospital Medical Information Network - Japan.
  • 05 Aug 2013 Status changed from recruiting to active, no longer recruiting as reported by University Hospital Medical Information Network - Japan record.
  • 20 Mar 2012 Planned End Date changed from 1 Sep 2013 to 1 Mar 2014 as reported by University Hospital Medical Information Network - Japan.

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top